Key regions: Australia, Italy, France, South Korea, Brazil
The Vaccines market in Romania has seen a significant increase in demand over the past few years.
Customer preferences: Romania has a high rate of vaccination, with many citizens opting to receive vaccines for various diseases. This trend is driven by the strong emphasis placed on preventative healthcare in the country, with many individuals taking proactive steps to maintain their health and wellbeing. Additionally, the government has implemented various vaccination programs to ensure that citizens have access to the necessary vaccines.
Trends in the market: One of the key trends in the Vaccines market in Romania is the increasing demand for vaccines for infectious diseases such as influenza, hepatitis, and meningitis. This trend is driven by a growing awareness of the importance of preventative healthcare, as well as an increase in the number of cases of these diseases. Another trend in the market is the rising demand for vaccines for non-infectious diseases such as cancer and autoimmune disorders. This trend is driven by advancements in medical research and an increasing understanding of the role that vaccines can play in preventing and treating these conditions.
Local special circumstances: Romania has a well-established healthcare system, with a large number of hospitals and clinics offering vaccines to patients. Additionally, the government has implemented various initiatives to improve access to vaccines, particularly for vulnerable populations such as children and the elderly. However, there are still some challenges in the market, including a lack of awareness among some individuals about the importance of vaccination and the potential risks of not receiving vaccines.
Underlying macroeconomic factors: The Vaccines market in Romania is influenced by a range of macroeconomic factors, including government policies, healthcare spending, and economic growth. The government has implemented various policies to support the development and distribution of vaccines, including subsidies and tax incentives for vaccine manufacturers. Additionally, healthcare spending in the country has been increasing in recent years, which has helped to support the growth of the Vaccines market. Finally, Romania has experienced steady economic growth in recent years, which has helped to drive demand for healthcare services, including vaccines.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
